(Total Views: 819)
Posted On: 08/08/2020 1:35:42 PM
Post# of 153903
If the m/m results prove better efficacy than SOC I don’t see how the FDA can deny EUA.
If they do ask for P3, then the other catalysts you are overlooking include BP partnership and/or selling Leronlimab to other countries.
If the situation weren’t as dire, I could envision the FDA kicking the can. If Leron is safe and even mildly effective I would imagine the FDA will be onboard with shooting it into as many COVID-ravaged bellies as possible.
I guess we’ll find out in the next few days.
If they do ask for P3, then the other catalysts you are overlooking include BP partnership and/or selling Leronlimab to other countries.
If the situation weren’t as dire, I could envision the FDA kicking the can. If Leron is safe and even mildly effective I would imagine the FDA will be onboard with shooting it into as many COVID-ravaged bellies as possible.
I guess we’ll find out in the next few days.
(8)
(0)
